← Open Payments lookup

CAROL MCCORMICK: Open Payments

NPI 1821004458 · SAN MARINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$863 in 39 payments from 16 companies in 2025. Trend: 2023 $761 · 2024 $956 · 2025 $863

Food & beverage: $863
CompanyPaymentsAmount
ABBVIE INC.10$165
E.R. Squibb & Sons, L.L.C.4$102
Axsome Therapeutics, Inc.3$73
Vanda Pharmaceuticals Inc.2$72
Teva Pharmaceuticals USA, Inc.3$67
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$61
Janssen Pharmaceuticals, Inc2$47
Collegium Pharmaceutical, Inc.2$47
Takeda Pharmaceuticals U.S.A., Inc.2$42
Bausch Health US, LLC2$35

Products named: VRAYLAR, COBENFY, HETLIOZ, CAPLYTA, UZEDY, Auvelity, INVEGA SUSTENNA, Jornay PM.

Industry payments across CA — which companies pay providers there.